Temozolomide Hydrochloride

Welcome to Dwaey, specifically on Temozolomide Hydrochloride page.
This medicine contains important and useful components, as it consists of
Temozolomide Hydrochloride is available in the market in concentration.

Generic Name of Temozolomide Hydrochloride - Learn More

Temozolomide Hydrochloride

Temozolomide Hydrochloride Precaution - What You Need to Know

Before starting Temozolomide Hydrochloride, it is critical to consult with a healthcare provider due to the potential risks associated with its use. Key precautions include:
- Bone Marrow Suppression: Temozolomide can cause significant bone marrow suppression, leading to leukopenia, thrombocytopenia, and anemia. Regular blood tests are required to monitor blood counts, especially during the first few cycles of treatment.
- Infections: As Temozolomide suppresses the immune system, it can increase the risk of infections. Patients should be closely monitored for signs of infection, such as fever, chills, or unusual fatigue, and treated promptly if necessary.
- Liver Function: Temozolomide is metabolized in the liver, and hepatic dysfunction can affect its metabolism. Liver function tests should be monitored, and dose adjustments may be necessary in patients with liver impairment.
- Pregnancy and Breastfeeding: Temozolomide is classified as a Category D drug during pregnancy, meaning it can cause harm to the fetus. It should not be used during pregnancy unless absolutely necessary. It is also excreted in breast milk, so breastfeeding is not recommended while taking this medication.
- Nausea and Vomiting: Patients may experience nausea and vomiting while on Temozolomide. Antiemetic medications may be required to manage these symptoms.
- Renal Impairment: Dose adjustments may be necessary in patients with renal impairment. Caution is advised as renal dysfunction can impact the clearance of the drug.

Temozolomide Hydrochloride Indication - Uses and Benefits

Temozolomide Hydrochloride is primarily indicated for:
- Glioblastoma Multiforme (GBM): Temozolomide is commonly used in the treatment of glioblastoma multiforme, a type of malignant brain tumor. It is typically prescribed after surgical resection and radiation therapy to help reduce tumor recurrence and improve survival.
- Anaplastic Astrocytoma: It is also used in the treatment of anaplastic astrocytoma, a rare and aggressive form of brain tumor. This use is typically as part of a combination therapy regimen.
- Recurrent Brain Tumors: Temozolomide is used for recurrent gliomas or other brain tumors that have not responded to other treatments.

Temozolomide Hydrochloride Contraindications - Important Warnings

Temozolomide Hydrochloride should be avoided in the following situations:
- Hypersensitivity: Patients with known hypersensitivity to Temozolomide or any of its components should not use this medication.
- Pregnancy: Due to its teratogenic potential, Temozolomide is contraindicated in pregnant women unless the potential benefit outweighs the risks.
- Severe Bone Marrow Suppression: Patients with severe bone marrow suppression or a low white blood cell count should not be given Temozolomide, as it can exacerbate these conditions.
- Liver Impairment: Patients with severe liver dysfunction should not receive Temozolomide, as the drug is metabolized in the liver and may lead to toxicity.
- Pregnancy Category D: This medication is contraindicated in pregnant women due to the risk of birth defects and fetal harm.

Temozolomide Hydrochloride Side Effects - What to Expect

Temozolomide Hydrochloride can cause both common and serious side effects:
- Common Side Effects:
- Nausea and vomiting: These symptoms occur in a significant number of patients, especially during the initial cycles of treatment.
- Fatigue: Many patients report tiredness and weakness during treatment with Temozolomide.
- Loss of appetite: Reduced appetite is common, which may lead to unintended weight loss.
- Headache: Temozolomide can cause headaches, particularly in patients with brain tumors.
- Serious Side Effects:
- Bone Marrow Suppression: This includes neutropenia, thrombocytopenia, and anemia. Regular blood counts should be monitored.
- Infections: Due to immunosuppression, patients are at increased risk of infections, which can be severe.
- Liver Toxicity: Temozolomide can cause elevated liver enzymes, and liver function should be regularly assessed during treatment.
- Severe Allergic Reactions: Patients may experience rash, itching, swelling (especially around the eyes, face, or lips), and difficulty breathing in case of an allergic reaction.
- Secondary Malignancies: There is a rare risk of developing secondary cancers, such as leukemia, after prolonged use of Temozolomide.

Temozolomide Hydrochloride Pregnancy Category ID - Safety Information

4

Temozolomide Hydrochloride Mode of Action - How It Works

Temozolomide is an alkylating agent that works by:
- DNA Alkylation: It is converted into an active metabolite that alkylates DNA, specifically by adding alkyl groups to the purine bases (guanine) in the DNA strand. This prevents DNA from replicating properly, leading to cell death.
- Interfering with Tumor Replication: By causing DNA damage, Temozolomide inhibits the replication of cancer cells, ultimately leading to their death. The DNA damage triggers the cell’s repair mechanisms, but the tumor cells are unable to repair the damage effectively.
- Selective Effect on Tumor Cells: Temozolomide preferentially affects rapidly dividing cancer cells, especially in tumors like glioblastoma, where cell division is more aggressive.

Temozolomide Hydrochloride Drug Interactions - What to Avoid

Temozolomide may interact with several medications and substances, affecting its effectiveness and safety:
- CYP Enzyme Inhibitors: Drugs that inhibit the CYP450 enzyme system, such as cimetidine, fluconazole, and antifungal drugs, may increase the levels of Temozolomide, leading to an increased risk of toxicity.
- CYP Enzyme Inducers: CYP450 inducers like phenytoin, carbamazepine, and rifampin can lower the effectiveness of Temozolomide by accelerating its metabolism.
- Other Chemotherapeutic Agents: When combined with other chemotherapies like alkylating agents or topoisomerase inhibitors, the risk of bone marrow suppression and immune suppression is increased, and careful monitoring is required.
- Vaccines: Immunosuppressive therapy, including Temozolomide, can impair the effectiveness of live vaccines. Patients should avoid live vaccines during treatment.
- Anticoagulants: Temozolomide may increase the risk of bleeding, particularly when taken with anticoagulants such as warfarin.

Temozolomide Hydrochloride Adult Dose - Recommended Dosage

The typical dosing regimen for Temozolomide in adults is:
- Glioblastoma Multiforme:
- Standard Regimen: A dose of 75 mg/m²/day is given once daily for 42 days alongside radiation therapy. Following this, a maintenance dose of 150 mg/m² is given on days 1-5 of a 28-day cycle, repeated every month.
- Anaplastic Astrocytoma: The dosing regimen is generally the same as for glioblastoma. The drug is given as a single dose per day for a specific period, followed by a maintenance dose.

Temozolomide Hydrochloride Child Dose - Dosage for Children

Temozolomide is generally not recommended for use in children, except for certain rare indications such as pediatric glioma. In such cases, the dose is often tailored according to the child’s weight and body surface area (mg/m²). Pediatric use should only occur under the supervision of an oncologist.

---

Temozolomide Hydrochloride is a powerful medication used in the treatment of aggressive brain tumors. Due to the risk of bone marrow suppression, liver toxicity, and infections, regular monitoring is essential. Patients should always consult a healthcare provider before initiating therapy to ensure the medication is appropriate for their condition and to minimize the risk of serious side effects.

Temozolomide Hydrochloride Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, the dose of Temozolomide may need to be adjusted. Specifically:
- Creatinine Clearance: In patients with a creatinine clearance of <60 mL/min, dose adjustments may be necessary. Doses should be reduced based on renal function, and close monitoring of renal function is recommended.
- Dialysis: It is not yet well-established how Temozolomide is cleared by dialysis, so caution is required in patients on hemodialysis.